COVID-19 vaccines for patients with cancer: benefits likely outweigh risks

JK Hwang, T Zhang, AZ Wang, Z Li - Journal of hematology & oncology, 2021 - Springer
Less than a year since the start of the COVID-19 pandemic, ten vaccines against SARS-CoV-
2 have been approved for at least limited use, with over sixty others in clinical trials. This …

Aging, obesity, and inflammatory age-related diseases

D Frasca, BB Blomberg, R Paganelli - Frontiers in immunology, 2017 - frontiersin.org
The increase in the prevalence of obesity represents a worldwide phenomenon in all age
groups and is pathologically and genetically correlated with several metabolic and …

Immunosuppressive agents and infectious risk in transplantation: managing the “net state of immunosuppression”

MB Roberts, JA Fishman - Clinical Infectious Diseases, 2021 - academic.oup.com
Successful solid organ transplantation reflects meticulous attention to the details of
immunosuppression, balancing risks for graft rejection against risks for infection. The “net …

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

JH Baird, DJ Epstein, JS Tamaresis, Z Ehlinger… - Blood …, 2021 - ashpublications.org
Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 has significantly improved
outcomes in the treatment of refractory or relapsed large B-cell lymphoma (LBCL). We …

B lymphocytes and cancer: a love–hate relationship

GJ Yuen, E Demissie, S Pillai - Trends in cancer, 2016 - cell.com
B Lymphocytes and Cancer: A Love–Hate Relationship: Trends in Cancer Skip to Main Content
Advertisement Trends in Cancer This journal offers authors two options (open access or …

Interleukin-35 induces regulatory B cells that suppress autoimmune disease

RX Wang, CR Yu, IM Dambuza, RM Mahdi… - Nature medicine, 2014 - nature.com
Abstract Interleukin-10 (IL-10)-producing regulatory B (Breg) cells suppress autoimmune
disease, and increased numbers of Breg cells prevent host defense to infection and promote …

Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers

HTT Do, CH Lee, J Cho - Cancers, 2020 - mdpi.com
Chemokines are chemotactic cytokines that mediate immune cell chemotaxis and lymphoid
tissue development. Recent advances have indicated that chemokines and their cognate …

Immune regulatory function of B cells

C Mauri, A Bosma - Annual review of immunology, 2012 - annualreviews.org
B cells are regarded for their capacity to produce antibody. However, recent advances in B
cell biology have capitalized on old findings and demonstrated that B cells also release a …

B cells responses and cytokine production are regulated by their immune microenvironment

MI Vazquez, J Catalan-Dibene, A Zlotnik - Cytokine, 2015 - Elsevier
The adaptive immune system consists of two types of lymphocytes: T and B cells. These two
lymphocytes originate from a common precursor, yet are fundamentally different with B cells …

B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile

J DeFuria, AC Belkina… - Proceedings of the …, 2013 - National Acad Sciences
Patients with type 2 diabetes (T2D) have disease-associated changes in B-cell function, but
the role these changes play in disease pathogenesis is not well established. Data herein …